Author

Amna Mumtaz Abbasi

University of Helsinki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Nurettin Nusret Curabaz· 2 shared Ziaurrehman TanoliiD· 2 shared Albert J. KooistraiD· 1 shared Alexander S. HauseriD· 1 shared Asifullah KhaniD· 1 shared Dinh‐Truong NguyeniD· 1 shared Hanh-Dung Le Phan· 1 shared Khalid SaeediD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Nurettin Nusret Curabaz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintJul 27, 2026

PrimeKG-Plus: a refreshed and rare-disease-enriched precision medicine knowledge graph

Trinh‐Trung‐Duong Nguyen, Thuy Nguyen-Phuong, Quy‐Hoai Nguyen…·Albert J. Kooistra

PrimeKG-Plus updates the PrimeKG knowledge graph with new data and rare-disease information, improving drug-disease connectivity and temporal relevance.

DOI 10.64898/2026.07.14.738415

humanstatistical model

𝕏 PostBluesky

Molecular BiologyBriefings in BioinformaticsPeer-reviewedNov 1, 2025

Data-driven strategies for drug repurposing: insights, recommendations, and case studies

Susanna Savander, Nurettin Nusret Curabaz, Amna Mumtaz Abbasi…·Ziaurrehman Tanoli

This paper compares drug-target interaction databases to identify repurposing opportunities and presents a pathway-based pipeline for predicting drug repositioning in cancer.

10 citationstop 4%

statistical modeldrug response / drug discovery

𝕏 PostBluesky